Somatostatin analogues

US9035021B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Rainer Albert · Basel, CH
• Wilfried Bauer · Lampenberg, CH
• David Bodmer · Klingnau, CH
• Christian Bruns · Glückstadt, DE
• Ivo Felner · Reinach, CH
• Heribert Hellstern · Heitersheim, DE
• Ian Lewis · Riehen, CH
• Mark Meisenbach · Durmenach, FR
• Gisbert Weckbecker · Biel-Benken, CH
• Bernhard Wietfeld · Weil am Rhein, DE

Key dates

• Filing date: Mar 16, 2011
• Grant date: May 19, 2015
• Expiry date: Jun 7, 2033

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention provides cyclo[{4-(NH2—C2H4—NH—CO—O—)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.